Choi, Jung-Hyun https://orcid.org/0000-0001-6941-463X
Correia de Sousa, Jaime https://orcid.org/0000-0001-6459-7908
Fletcher, Monica https://orcid.org/0000-0002-9700-3552
Gabutti, Giovanni https://orcid.org/0000-0002-7259-4923
Harrington, Lauriane https://orcid.org/0000-0001-6765-8606
Holden, Michael https://orcid.org/0000-0001-9454-6159
Kim, Hyungwoo https://orcid.org/0000-0001-8675-0192
Michel, Jean-Pierre https://orcid.org/0000-0003-0718-4394
Mukherjee, Piyali https://orcid.org/0000-0002-9895-3795
Nolan, Terry https://orcid.org/0000-0001-6018-3863
Welte, Tobias https://orcid.org/0000-0002-9947-7356
Maggi, Stefania https://orcid.org/0000-0002-0453-8663
Funding for this research was provided by:
GlaxoSmithKline
University of Geneva
Article History
Received: 8 September 2021
Accepted: 24 October 2021
First Online: 10 January 2022
Declarations
:
: LH, PM, and HK are employees of the GSK group of companies. PM report ownership of shares and/or restricted shares of the GSK group of companies. TN reports personal fees from GSK during the conduct of the study and personal fees from GSK, outside the submitted work. GG reports personal fees from GSK, Sanofi Pasteur Italy, MSD, Merck, Pfizer, Seqirus and Emergent Biosolutions, outside the submitted work. SM reports grants from GSK, MSD, Takeda and Sanofi, and personal fees from GSK, outside the submitted work. HK reports other relationships with GSK, during the conduct of the study. TW reports grants from the German Ministry of Research and Education, and personal fees from GSK, MSD, AstraZeneca, BioNTech, Pfizer, Johnson&Johnson, during the conduct of the study. JCdS reports personal fees from AstraZeneca and Mundipharma, non-financial support from AstraZeneca and other relationships with Boheringer Ingelheim, GSK, AstraZeneca, Mundipharma, Bial and Novartis, outside the submitted work. JHC, MF, MH and JPM have nothing to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.